secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVS HEALTH Corp (CVS)
CIK:        0000064803
Form:       8-K
Filed at:   2025-05-01T23:59:59+00:00
Accession:  0000064803-25-000012
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CVS Health Q1 Adj EPS $2.25 vs $1.31 YoY; raises FY25 Adj EPS guidance to $6.00-$6.20
--------------------------------------------------------------------------------

- Total revenues $94.6B, up 7.0% YoY; GAAP diluted EPS $1.41, Adjusted EPS $2.25.
- Operating income $3.374B vs $2.271B YoY; adjusted operating income $4.579B vs $2.957B.
- Full-year 2025 guidance: GAAP diluted EPS revised to $4.23-$4.43 from $4.58-$4.83; Adjusted EPS raised to $6.00-$6.20 from $5.75-$6.00.
- CVS Health to exit individual exchange business; introduces Aetna solutions and CVS Caremark GLP-1 formulary update.
- Cash flow from ops $4.6B in Q1; FY25 CF guidance raised to ~$7.0B from ~$6.5B.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/64803/000006480325000012/0000064803-25-000012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/64803/000006480325000012/cvs-20250501.htm
  HTML page:      https://secwatch.observer/filing/0000064803-25-000012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer